US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), Universite Paris est Creteil Val de Marne, Baylor Research Institute, Assistance Publique-Hopitaux de Paris (APHP) on March 17 for "Recombinant proteins with CD40 activating properties" (American, French Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,147, issued on March 17, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), Universite Paris est Creteil Val de Marne (Creteil, France), Baylor Research Institute (Dallas) and Assistance Publique-Hopitaux de Paris (APHP) (Paris).

"Recombinant proteins with CD40 activating properties" was invented by Yves Levy (Paris), Valentina Ceglia (Dallas), Sandra Zurawski (Midlotian, Texas) and Gerard Zurawski (Midlothian, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "CD40 activating proteins comprising recombinant proteins with CD40 agonist antibodies or their antigen-binding fragments fused or linked to CD40 li...